# Reynolds Consumer Products Inc.: financial statements, quarterly

REYN · Nasdaq · CIK 1786431 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/reyn.md) · [Financials](/companies/reyn/financials.md) · [Filings](/companies/reyn/filings.md) · [Insiders](/companies/reyn/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/reyn/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [940](/filings/0001628280-24-035405.md) | [935](/filings/0001628280-24-044208.md) | [1,006 d](/filings/0001628280-26-005284.md) | [833](/filings/0001628280-25-020839.md) | [930](/filings/0001628280-25-036571.md) | [910](/filings/0001628280-25-046942.md) | [1,020 d](/filings/0001628280-26-005284.md) | [818](/filings/0001628280-26-030951.md) | [938](/filings/0001628280-25-036571.md) | [931](/filings/0001628280-25-046942.md) | [1,034 d](/filings/0001628280-26-005284.md) | [877](/filings/0001628280-26-030951.md) |
| Cost of revenue | $m | [712](/filings/0001628280-24-035405.md) | [686](/filings/0001628280-24-044208.md) | [697 d](/filings/0001628280-26-005284.md) | [632](/filings/0001628280-25-020839.md) | [674](/filings/0001628280-25-036571.md) | [671](/filings/0001628280-25-046942.md) | [740 d](/filings/0001628280-26-005284.md) | [629](/filings/0001628280-26-030951.md) | [712](/filings/0001628280-25-036571.md) | [698](/filings/0001628280-25-046942.md) | [768 d](/filings/0001628280-26-005284.md) | [670](/filings/0001628280-26-030951.md) |
| Gross profit | $m | [228](/filings/0001628280-24-035405.md) | [249](/filings/0001628280-24-044208.md) | [309 d](/filings/0001628280-26-005284.md) | [201](/filings/0001628280-25-020839.md) | [256](/filings/0001628280-25-036571.md) | [239](/filings/0001628280-25-046942.md) | [280 d](/filings/0001628280-26-005284.md) | [189](/filings/0001628280-26-030951.md) | [226](/filings/0001628280-25-036571.md) | [233](/filings/0001628280-25-046942.md) | [266 d](/filings/0001628280-26-005284.md) | [207](/filings/0001628280-26-030951.md) |
| Selling, general and administrative | $m | [107](/filings/0001628280-24-035405.md) | [115](/filings/0001628280-24-044208.md) | [103 d](/filings/0001628280-26-005284.md) | [111](/filings/0001628280-25-020839.md) | [116](/filings/0001628280-25-036571.md) | [101](/filings/0001628280-25-046942.md) | [100 d](/filings/0001628280-26-005284.md) | [104](/filings/0001628280-26-030951.md) | [96.0](/filings/0001628280-25-036571.md) | [99.0](/filings/0001628280-25-046942.md) | [82.0 d](/filings/0001628280-26-005284.md) | [109](/filings/0001628280-26-030951.md) |
| Interest expense | $m | [31.0](/filings/0001628280-23-028426.md) | [31.0](/filings/0001628280-23-037584.md) | [28.0 d](/filings/0001628280-24-003623.md) | [25.0](/filings/0001628280-24-021395.md) | [25.0](/filings/0001628280-25-036571.md) | [25.0](/filings/0001628280-25-046942.md) | [22.0 d](/filings/0001628280-26-005284.md) | [21.0](/filings/0001628280-26-030951.md) | [22.0](/filings/0001628280-25-036571.md) | [21.0](/filings/0001628280-25-046942.md) | [23.0 d](/filings/0001628280-26-005284.md) | [21.0](/filings/0001628280-26-030951.md) |
| Income tax | $m | [23.0](/filings/0001628280-24-035405.md) | [25.0](/filings/0001628280-24-044208.md) | [41.0 d](/filings/0001628280-26-005284.md) | [16.0](/filings/0001628280-25-020839.md) | [18.0](/filings/0001628280-25-036571.md) | [27.0](/filings/0001628280-25-046942.md) | [37.0 d](/filings/0001628280-26-005284.md) | [11.0](/filings/0001628280-26-030951.md) | [23.0](/filings/0001628280-25-036571.md) | [23.0](/filings/0001628280-25-046942.md) | [36.0 d](/filings/0001628280-26-005284.md) | [18.0](/filings/0001628280-26-030951.md) |
| Net income | $m | [66.0](/filings/0001628280-24-044208.md) | [78.0](/filings/0001628280-24-044208.md) | [137 d](/filings/0001628280-26-005284.md) | [49.0](/filings/0001628280-25-046942.md) | [97.0](/filings/0001628280-25-046942.md) | [86.0](/filings/0001628280-25-046942.md) | [121 d](/filings/0001628280-26-005284.md) | [31.0](/filings/0001628280-26-030951.md) | [73.0](/filings/0001628280-25-046942.md) | [79.0](/filings/0001628280-25-046942.md) | [117 d](/filings/0001628280-26-005284.md) | [59.0](/filings/0001628280-26-030951.md) |
| Diluted EPS | $ per share | [0.32](/filings/0001628280-24-035405.md) | [0.37](/filings/0001628280-24-044208.md) | not reported | [0.23](/filings/0001628280-25-020839.md) | [0.46](/filings/0001628280-25-036571.md) | [0.41](/filings/0001628280-25-046942.md) | not reported | [0.15](/filings/0001628280-26-030951.md) | [0.35](/filings/0001628280-25-036571.md) | [0.38](/filings/0001628280-25-046942.md) | not reported | [0.28](/filings/0001628280-26-030951.md) |
| Basic EPS | $ per share | [0.32](/filings/0001628280-24-035405.md) | [0.37](/filings/0001628280-24-044208.md) | not reported | [0.23](/filings/0001628280-25-020839.md) | [0.46](/filings/0001628280-25-036571.md) | [0.41](/filings/0001628280-25-046942.md) | not reported | [0.15](/filings/0001628280-26-030951.md) | [0.35](/filings/0001628280-25-036571.md) | [0.38](/filings/0001628280-25-046942.md) | not reported | [0.28](/filings/0001628280-26-030951.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [83.0](/filings/0001628280-23-028426.md) | [124](/filings/0001628280-23-037584.md) | [115](/filings/0001628280-25-003936.md) | [135](/filings/0001628280-24-021395.md) | [101](/filings/0001628280-24-035405.md) | [96.0](/filings/0001628280-24-044208.md) | [137](/filings/0001628280-26-005284.md) | [58.0](/filings/0001628280-25-020839.md) | [57.0](/filings/0001628280-25-036571.md) | [53.0](/filings/0001628280-25-046942.md) | [147](/filings/0001628280-26-030951.md) | [71.0](/filings/0001628280-26-030951.md) |
| Current assets | $m | [1,146](/filings/0001628280-23-028426.md) | [1,106](/filings/0001628280-23-037584.md) | [1,041](/filings/0001628280-25-003936.md) | [1,091](/filings/0001628280-24-021395.md) | [1,113](/filings/0001628280-24-035405.md) | [1,105](/filings/0001628280-24-044208.md) | [1,101](/filings/0001628280-26-005284.md) | [1,050](/filings/0001628280-25-020839.md) | [1,063](/filings/0001628280-25-036571.md) | [1,084](/filings/0001628280-25-046942.md) | [1,116](/filings/0001628280-26-030951.md) | [1,105](/filings/0001628280-26-030951.md) |
| Total assets | $m | [4,882](/filings/0001628280-23-028426.md) | [4,838](/filings/0001628280-23-037584.md) | [4,780](/filings/0001628280-25-003936.md) | [4,858](/filings/0001628280-24-021395.md) | [4,865](/filings/0001628280-24-035405.md) | [4,843](/filings/0001628280-24-044208.md) | [4,873](/filings/0001628280-26-005284.md) | [4,839](/filings/0001628280-25-020839.md) | [4,861](/filings/0001628280-25-036571.md) | [4,896](/filings/0001628280-25-046942.md) | [4,936](/filings/0001628280-26-030951.md) | [4,930](/filings/0001628280-26-030951.md) |
| Current liabilities | $m | [465](/filings/0001628280-23-028426.md) | [467](/filings/0001628280-23-037584.md) | [478](/filings/0001628280-25-003936.md) | [517](/filings/0001628280-24-021395.md) | [523](/filings/0001628280-24-035405.md) | [543](/filings/0001628280-24-044208.md) | [539](/filings/0001628280-26-005284.md) | [584](/filings/0001628280-25-020839.md) | [575](/filings/0001628280-25-036571.md) | [559](/filings/0001628280-25-046942.md) | [577](/filings/0001628280-26-030951.md) | [616](/filings/0001628280-26-030951.md) |
| Total liabilities | $m | [3,023](/filings/0001628280-23-028426.md) | [2,946](/filings/0001628280-23-037584.md) | [2,797](/filings/0001628280-25-003936.md) | [2,869](/filings/0001628280-24-021395.md) | [2,825](/filings/0001628280-24-035405.md) | [2,778](/filings/0001628280-24-044208.md) | [2,731](/filings/0001628280-26-005284.md) | [2,717](/filings/0001628280-25-020839.md) | [2,713](/filings/0001628280-25-036571.md) | [2,716](/filings/0001628280-25-046942.md) | [2,683](/filings/0001628280-26-030951.md) | [2,665](/filings/0001628280-26-030951.md) |
| Long-term debt | $m | [2,056](/filings/0001628280-23-028426.md) | [1,981](/filings/0001628280-23-037584.md) | [1,832](/filings/0001628280-25-003936.md) | [1,833](/filings/0001628280-24-021395.md) | [1,784](/filings/0001628280-24-035405.md) | [1,735](/filings/0001628280-24-044208.md) | [1,686](/filings/0001628280-26-005284.md) | [1,621](/filings/0001628280-25-020839.md) | [1,617](/filings/0001628280-25-036571.md) | [1,613](/filings/0001628280-25-046942.md) | [1,580](/filings/0001628280-26-030951.md) | [1,530](/filings/0001628280-26-030951.md) |
| Current portion of debt | $m | [25.0](/filings/0001628280-23-028426.md) | [0.0](/filings/0001628280-23-037584.md) | [0.0](/filings/0001628280-24-044208.md) | [0.0](/filings/0001628280-24-021395.md) | [0.0](/filings/0001628280-24-035405.md) | [0.0](/filings/0001628280-24-044208.md) | [0.0](/filings/0001628280-25-046942.md) | [16.0](/filings/0001628280-25-020839.md) | [16.0](/filings/0001628280-25-036571.md) | [16.0](/filings/0001628280-25-046942.md) | [0.0](/filings/0001628280-26-030951.md) | [0.0](/filings/0001628280-26-030951.md) |
| Shareholders' equity | $m | [1,859](/filings/0001628280-24-044208.md) | [1,892](/filings/0001628280-24-044208.md) | [1,983](/filings/0001628280-26-005284.md) | [1,989](/filings/0001628280-25-046942.md) | [2,040](/filings/0001628280-25-046942.md) | [2,065](/filings/0001628280-25-046942.md) | [2,142](/filings/0001628280-26-030951.md) | [2,122](/filings/0001628280-26-030951.md) | [2,148](/filings/0001628280-25-046942.md) | [2,180](/filings/0001628280-25-046942.md) | [2,253](/filings/0001628280-26-030951.md) | [2,265](/filings/0001628280-26-030951.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [119 d](/filings/0001628280-24-035405.md) | [216 d](/filings/0001628280-24-044208.md) | [221 d](/filings/0001628280-26-005284.md) | [99.0](/filings/0001628280-25-020839.md) | [84.0 d](/filings/0001628280-25-036571.md) | [124 d](/filings/0001628280-25-046942.md) | [182 d](/filings/0001628280-26-005284.md) | [56.0](/filings/0001628280-26-030951.md) | [91.0 d](/filings/0001628280-25-036571.md) | [93.0 d](/filings/0001628280-25-046942.md) | [237 d](/filings/0001628280-26-005284.md) | [71.0](/filings/0001628280-26-030951.md) |
| Capital expenditure | $m | [29.0 d](/filings/0001628280-24-035405.md) | [26.0 d](/filings/0001628280-24-044208.md) | [27.0 d](/filings/0001628280-26-005284.md) | [29.0](/filings/0001628280-25-020839.md) | [19.0 d](/filings/0001628280-25-036571.md) | [31.0 d](/filings/0001628280-25-046942.md) | [41.0 d](/filings/0001628280-26-005284.md) | [39.0](/filings/0001628280-26-030951.md) | [40.0 d](/filings/0001628280-25-036571.md) | [45.0 d](/filings/0001628280-25-046942.md) | [37.0 d](/filings/0001628280-26-005284.md) | [44.0](/filings/0001628280-26-030951.md) |
| Dividends paid | $m | [48.0 d](/filings/0001628280-24-035405.md) | [48.0 d](/filings/0001628280-24-044208.md) | [48.0 d](/filings/0001628280-26-005284.md) | [48.0](/filings/0001628280-25-020839.md) | [48.0 d](/filings/0001628280-25-036571.md) | [48.0 d](/filings/0001628280-25-046942.md) | [48.0 d](/filings/0001628280-26-005284.md) | [48.0](/filings/0001628280-26-030951.md) | [48.0 d](/filings/0001628280-25-036571.md) | [48.0 d](/filings/0001628280-25-046942.md) | [48.0 d](/filings/0001628280-26-005284.md) | [48.0](/filings/0001628280-26-030951.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [210](/filings/0001628280-23-028426.md) | [210](/filings/0001628280-23-037584.md) | [210](/filings/0001628280-24-021395.md) | [210](/filings/0001628280-24-035405.md) | [210](/filings/0001628280-24-044208.md) | [210](/filings/0001628280-25-020839.md) | [210](/filings/0001628280-25-036571.md) | [210](/filings/0001628280-25-046942.md) | [210](/filings/0001628280-26-030951.md) | [210](/filings/0001628280-25-036571.md) | [210](/filings/0001628280-25-046942.md) | [212](/filings/0001628280-26-030951.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 210,767,377 at 2026-05-01, from the cover of the [10-Q filed 2026-05-06](/filings/0001628280-26-030951.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.